Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
eNrNWF1v2jAUfedXRHl3Qiht0ylQbazdkFaN0aJNe6lMclPMjJ36A2h//RxCNzola2tqqS9IxMm5N77nnnvi5HS9oN4ShCSc9fwoaPsesJRnhN30/MnVOYr9034rmeMl3rntOGgHUcf3Uoql7PnlajAFzGTw4+LLRzDPg/D7LS/h0zmk6tF9WhEafMZydoGL8h4vWXKSeQtQM571/EKrzVUvkUqYLPorLn7JAqeQhNsru6vz6+7u9SQswZ6BqiWIL5jd1ILmwgoz1UIAUwOs4IaLu3ro9LoTHx+127FVCCLHILkWKYywmo0EX5IMsvpImEqwCpKvsksQSwqqDFILHs7ThbQCx3O8HsPtsD7p92Z1oNYKtVF0fNjtxieHBydRdGIVSuxsVT15zEuExfVBFHW6R1GYi7DA98CIQIZvlCi8BooyQ2ukGaCci4WmWJkWQBkghhkvsFAk1RQkogTML0YUYTrVC8LAssAjLhSmjkpL5OAxSR3FEXD7JIUyIguK74K5LGy3CgtslkEYKXH3IuUbXAnDAlP7f/GZpjR8YdaTrfQ4yrhUtgHXTDUo0PnYdiMGnClYN1fUTjTVestFAvL1YO85qx8YIz2lJLXVRaNcGqSajIfNsvjmFOUDljAR7iTlO2EZX8nXl6pdajjKvtio7X9GdTeOY+s+/GlY2DDpzrTgBYRGwojcR5mGLOf7apIhdj3UA63fFqM33o2nmEKDe0OWGmeo/GA2nTWLu0asFmpBP51d2XLsmwZxd7n5WwtNst4fdtgNABdTxTC6MfGX90clEs/w9d34oGNHaVGvQTOlCvkuDFerVTDDEklsNiswTfgmB82OQXD3aeLEhVSurJJrR6lPqyn8sjLbdu1TPmVf7719fuvxa2MooWGPWlQC70yGh2evr+x/jbeztEePlMhdmI1J3uiFK9+lp7WI+80SU1d2LoxAfM1z0nBi1MjLJKxOq/qtJCxPqvqt33I1UUc=
ARRbLyR5r4thAHyv